Clarivate (NYSE: CLVT) rarely commands headlines, yet it sits at the center of how innovation is protected, monetized, and defended. The company provides data, analytics, and workflow tools that support intellectual property management, scientific research, regulatory compliance, and legal decision-making.Read more
Clarivate looks better placed than many expect as it bakes new AI features into the tools that universities, drug makers, and patent teams already rely on, making it harder to switch away. The big question is whether that edge can outpace threats like open data, fast-moving AI rivals, and heavy debt that could squeeze profits.Read more
Clarivate faces a squeeze as free research and new AI tools make it easier for customers to find cheaper alternatives, while tougher rules and platform headaches push costs up and loyalty down. Yet strong renewals and a shift toward simpler subscriptions could keep the business steadier than bears expect—if its new AI features stick.Read more
Clarivate is trying to turn its research and patent data products into stickier, subscription-based tools that bake in AI features and deepen customers’ daily workflows. The upside is steadier, higher-quality revenue, but tighter university budgets, more free alternatives, and fast-moving competitors could weaken demand and pricing power.Read more
Clarivate Plc provides information services in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Intellectual Property, and Life Sciences & Healthcare. The company offers scientific and academic research solutions; Web of Science Research Intelligence, an AI-native solution; ProQuest solutions to access multidisciplinary curated content, such as databases, dissertations, news, primary sources, books, and video formats; library software, including Alma, library services platform; and Vega and Polaris for public libraries. It also provides patent maintenance and administrative services; Derwent Innovation, an AI-powered search; Derwent World Patents Index to identify related concepts in patent publications and navigate new or unfamiliar technology categories; CompuMark, a trademark search and watch solutions; IP Recordals managed services; and RiskMark, an AI-powered tool for evaluating trademark risk and argument drafting support. In addition, the company offers IPfolio, a management platform; FoundationIP solution for law firms; Cortellis for decisions related to assessing the market, analyzing competitors, regulatory compliance, and drug safety; Regulatory Intelligence platform; commercial solutions; and Medtech solutions. It serves academic institutions, government agencies, and life sciences, and pharmaceutical companies. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.
